Silo pharma advances psychedelic patent portfolio

Englewood cliffs nj, aug. 25, 2021 (globe newswire) -- silo pharma, inc. (otcqb: silo), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced the filing of three distinct patent cooperation treaty (pct) patent applications pertaining to the central nervous system delivery of unique anti-inflammatory therapeutics coupled with psilocybin.
SILO Ratings Summary
SILO Quant Ranking